Tag Archives: California

California SB 17 Enacted

On October 9, California Governor Jerry Brown signed SB 17, legislation mandating advance notice and price transparency reporting for drugs experiencing greater than 16% increases in WAC over three calendar years and new drugs introduced at a WAC above the Medicare Part D specialty drug threshold.  The legislation will take effect January 1, 2018, although the reporting requirements to the Office of Statewide Health Planning and Development will begin in the first quarter of 2019.… More

State Drug Price Transparency Legislation: What to Watch for This Fall

After a slow-down during the summer recesses, action on the drug price transparency front is beginning to increase as we enter the fall season.  Here are a few states to watch in the coming months:

California

California’s price transparency legislation, SB 17, passed the legislature on September 13, and now goes to Governor Jerry Brown for his signature.  The legislation had passed the Senate by a 28-10 vote on May 30,… More

California Price Transparency Legislation Passes Legislature

California’s drug price transparency legislation, SB 17, passed the State Assembly on September 11 by a vote of 66-9.  The bill included several amendments to the version of the bill that passed the State Senate at the end of May.  The State Senate then passed the amended legislation on September 13.  Among the most important amendments were changes to “triggers” for price reporting, and for advance notice requirements relative to WAC increases.… More